Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single‐centre study with focus on emerging pathogens

By  

MYCOSES (ELECTRONIC), Vol. 58, Iss. 6, 2015-06 ,pp. : 325-336

John Wiley & Sons Inc

Access to resources Recommend Favorite

Atovaquone for Prophylaxis of Toxoplasmosis after Allogeneic Hematopoietic Stem Cell Transplantation

By  

Acta Haematologica, Vol. 134, Iss. 3, 2015-05 ,pp. : 146-154

Karger

Access to resources Recommend Favorite

Risk factors for invasive mold infections following allogeneic hematopoietic stem cell transplantation: A single center study of 190 recipients

By Li Lili   Wang Jianmin   Zhang Weiping   Yang Jianmin   Chen Li   Lv Shuqing  

Scandinavian Journal of Infectious Diseases, Vol. 44, Iss. 2, 2012-02 ,pp. : 100-107

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness of antibacterial prophylaxis with non‐absorbable polymyxin B compared to levofloxacin after allogeneic hematopoietic stem cell transplantation

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 1398-2273, Iss. 5, 2015-10 ,pp. : 647-654

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effectiveness of antibacterial prophylaxis with non‐absorbable polymyxin B compared to levofloxacin after allogeneic hematopoietic stem cell transplantation

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 5, 2015-10 ,pp. : 647-654

John Wiley & Sons Inc

Access to resources Recommend Favorite